Douglas J. Kojetin

Find an error

Name: Kojetin, Douglas
Organization: The Scripps Research Institute , USA
Department: Department of Molecular Therapeutics
Title: Associate(PhD)
Co-reporter:Ian Mitchelle S. de Vera, Jie Zheng, Scott Novick, Jinsai Shang, ... Douglas J. Kojetin
Structure 2017 Volume 25, Issue 10(Volume 25, Issue 10) pp:
Publication Date(Web):3 October 2017
DOI:10.1016/j.str.2017.07.019
•Structural and biophysical analysis of SRC-2 RID/PPARγ-RXRα interaction•Ligand binding to RXRα dominates over PPARγ to enhance interaction with SRC-2 RID•DNA binding to PPARγ/RXRα influences SRC-2 RID affinity and vice versa•Ligand and DNA cooperatively enhance SRC-2 RID binding to PPARγ/RXRαNuclear receptor (NR) transcription factors bind various coreceptors, small-molecule ligands, DNA response element sequences, and transcriptional coregulator proteins to affect gene transcription. Small-molecule ligands and DNA are known to influence receptor structure, coregulator protein interaction, and function; however, little is known on the mechanism of synergy between ligand and DNA. Using quantitative biochemical, biophysical, and solution structural methods, including 13C-detected nuclear magnetic resonance and hydrogen/deuterium exchange (HDX) mass spectrometry, we show that ligand and DNA cooperatively recruit the intrinsically disordered steroid receptor coactivator-2 (SRC-2/TIF2/GRIP1/NCoA-2) receptor interaction domain to peroxisome proliferator-activated receptor gamma-retinoid X receptor alpha (PPARγ-RXRα) heterodimer and reveal the binding determinants of the complex. Our data reveal a thermodynamic mechanism by which DNA binding propagates a conformational change in PPARγ-RXRα, stabilizes the receptor ligand binding domain dimer interface, and impacts ligand potency and cooperativity in NR coactivator recruitment.Download high-res image (149KB)Download full-size image
Co-reporter:Travis S. Hughes, Jinsai Shang, Richard Brust, Ian Mitchelle S. de Vera, Jakob Fuhrmann, Claudia Ruiz, Michael D. Cameron, Theodore M. Kamenecka, and Douglas J. Kojetin
Journal of Medicinal Chemistry 2016 Volume 59(Issue 22) pp:10335-10341
Publication Date(Web):October 26, 2016
DOI:10.1021/acs.jmedchem.6b01340
In a previous study, a cocrystal structure of PPARγ bound to 2-chloro-N-(3-chloro-4-((5-chlorobenzo[d]thiazol-2-yl)thio)phenyl)-4-(trifluoromethyl)benzenesulfonamide (1, T2384) revealed two orthosteric pocket binding modes attributed to a concentration-dependent biochemical activity profile. However, 1 also bound an alternate/allosteric site that could alternatively account for the profile. Here, we show ligand aggregation afflicts the activity profile of 1 in biochemical assays. However, ligand-observed fluorine (19F) and protein-observed NMR confirms 1 binds PPARγ with two orthosteric binding modes and to an allosteric site.
Co-reporter:Ian Mitchelle S. de Vera, Pankaj K. Giri, Paola Munoz-Tello, Richard Brust, Jakob Fuhrmann, Edna Matta-Camacho, Jinsai Shang, Sean Campbell, Henry D. Wilson, Juan Granados, William J. Gardner Jr., Trevor P. Creamer, Laura. A. Solt, and Douglas J. Kojetin
ACS Chemical Biology 2016 Volume 11(Issue 7) pp:1795
Publication Date(Web):April 29, 2016
DOI:10.1021/acschembio.6b00037
Nurr1/NR4A2 is an orphan nuclear receptor, and currently there are no known natural ligands that bind Nurr1. A recent metabolomics study identified unsaturated fatty acids, including arachidonic acid and docosahexaenoic acid (DHA), that interact with the ligand-binding domain (LBD) of a related orphan receptor, Nur77/NR4A1. However, the binding location and whether these ligands bind other NR4A receptors were not defined. Here, we show that unsaturated fatty acids also interact with the Nurr1 LBD, and solution NMR spectroscopy reveals the binding epitope of DHA at its putative ligand-binding pocket. Biochemical assays reveal that DHA-bound Nurr1 interacts with high affinity with a peptide derived from PIASγ, a protein that interacts with Nurr1 in cellular extracts, and DHA also affects cellular Nurr1 transactivation. This work is the first structural report of a natural ligand binding to a canonical NR4A ligand-binding pocket and indicates a natural ligand can bind and affect Nurr1 function.
Co-reporter:Travis S. Hughes, Michael J. Chalmers, Scott Novick, Dana S. Kuruvilla, ... Douglas J. Kojetin
Structure (11 January 2012) Volume 20(Issue 1) pp:139-150
Publication Date(Web):11 January 2012
DOI:10.1016/j.str.2011.10.018
Ligand binding to proteins is not a static process, but rather involves a number of complex dynamic transitions. A flexible ligand can change conformation upon binding its target. The conformation and dynamics of a protein can change to facilitate ligand binding. The conformation of the ligand, however, is generally presumed to have one primary binding mode, shifting the protein conformational ensemble from one state to another. We report solution nuclear magnetic resonance (NMR) studies that reveal peroxisome proliferator-activated receptor γ (PPARγ) modulators can sample multiple binding modes manifesting in multiple receptor conformations in slow conformational exchange. Our NMR, hydrogen/deuterium exchange and docking studies reveal that ligand-induced receptor stabilization and binding mode occupancy correlate with the graded agonist response of the ligand. Our results suggest that ligand and receptor dynamics affect the graded transcriptional output of PPARγ modulators.Graphical AbstractDownload high-res image (298KB)Download full-size imageHighlights► PPARγ ligands can sample multiple binding modes in slow exchange ► Multiple binding modes manifest in distinct receptor conformations in slow exchange ► Graded agonism correlates with differences in receptor dynamics ► Both ligand and receptor dynamics impact function
4'-[(2,3-dimethyl-5-{[(1s)-1-(4-nitrophenyl)ethyl]carbamoyl}-1h-i Ndol-1-yl)methyl]-2-biphenylcarboxylic Acid
tert-Butyl 8-amino-3,4-dihydroisoquinoline-2(1H)-carboxylate
Raltegravir
Benzamide, 2-chloro-5-nitro-N-5-quinolinyl-
Benzamide, 2-chloro-N-(3-ethylphenyl)-5-nitro-
Benzamide, N-[1,1'-biphenyl]-2-yl-2-chloro-5-nitro-
Benzamide, N-[1,1'-biphenyl]-3-yl-2-chloro-5-nitro-
2-chloro-N-(3-methoxyphenyl)-5-nitrobenzamide
Benzamide, 2-chloro-N-(3-methylphenyl)-5-nitro-
Benzamide, N-[1,1'-biphenyl]-4-yl-2-chloro-5-nitro-